PRESS RELEASE published on 08/04/2023 at 07:00, 2 years 7 months ago Newron announces H1 2023 results and provides R&D update
PRESS RELEASE published on 05/15/2023 at 07:00, 2 years 10 months ago Newron presents exciting new data from study 014/015 at CINP World Congress of Neuropsychopharmacology and the 2023 Congress of the Schizophrenia International Research Society (SIRS)
PRESS RELEASE published on 05/03/2023 at 07:00, 2 years 10 months ago Newron to present at the 34th CINP World Congress of Neuropsychopharmacology and the 2023 Congress of the Schizophrenia International Research Society (SIRS)
PRESS RELEASE published on 05/02/2023 at 07:00, 2 years 10 months ago Newron announces Senior Management Team changes
PRESS RELEASE published on 04/18/2023 at 12:15, 2 years 11 months ago Newron announces AGM 2023 results
PRESS RELEASE published on 03/28/2023 at 12:30, 2 years 11 months ago Newron presents six-month interim data from the first 100 patients randomized in study 014/015 at the 31st European Congress of Psychiatry
PRESS RELEASE published on 03/20/2023 at 07:00, 3 years ago Newron reports compelling topline results from all patients in Study 014, its Phase II clinical trial evaluating evenamide as add-on therapy for treatment-resistant schizophrenia
PRESS RELEASE published on 03/17/2023 at 07:00, 3 years ago Newron to present at the 31st European Congress of Psychiatry
PRESS RELEASE published on 03/14/2023 at 07:00, 3 years ago Newron announces 2022 financial results and provides outlook for 2023
PRESS RELEASE published on 02/16/2023 at 07:00, 3 years 1 month ago Newron reports striking one-year interim efficacy results from its Phase II clinical trial evaluating evenamide as add-on therapy for patients with treatment-resistant schizophrenia
Published on 03/28/2026 at 01:00, 4 hours 26 minutes ago Battery X Metals Announces Confidential Submission of Amended Draft Registration Statement with the U.S. Securities and Exchange Commission in Connection with Proposed U.S. National Securities Exchange Initial Public Offering
Published on 03/28/2026 at 00:55, 4 hours 31 minutes ago Notification of Relevant Change to Significant Shareholder
Published on 03/28/2026 at 00:50, 4 hours 36 minutes ago "Rise" Selected as NASA Artemis II Moon Mascot
Published on 03/27/2026 at 22:45, 6 hours 41 minutes ago Caledonia Mining Corporation Plc - Notification of Relevant Change to Significant Shareholder
Published on 03/27/2026 at 22:30, 6 hours 56 minutes ago Usha Resources Completes Extended Induced Polarization Survey at the Southern Arm Property
Published on 03/28/2026 at 01:42, 3 hours 44 minutes ago EQS-Adhoc: Raiffeisen Bank International AG: Agreement on the acquisition of Garanti BBVA Group Romania
Published on 03/27/2026 at 21:58, 7 hours 28 minutes ago Kaufman & Broad SA: Availability of the Universal Registration Document 2025
Published on 03/27/2026 at 21:58, 7 hours 28 minutes ago Kaufman & Broad SA: Mise à disposition du Document d'Enregistrement Universel 2025
Published on 03/27/2026 at 20:08, 9 hours 18 minutes ago EQS-Adhoc: CECONOMY AG: Information on the ongoing public takeover process – uncertainty regarding FDI clearance in Austria
Published on 03/27/2026 at 19:30, 9 hours 56 minutes ago Turning Potential into Reality: Future 500 Ignites Scale-Up Momentum in Europe
Published on 03/27/2026 at 19:06, 10 hours 20 minutes ago Mersen : Déclaration des transactions sur actions propres
Published on 03/27/2026 at 18:52, 10 hours 34 minutes ago Crédit Agricole CIB announces the publication of its 2025 Universal Registration Document
Published on 03/27/2026 at 18:52, 10 hours 34 minutes ago Crédit Agricole CIB annonce la publication de son Document d’enregistrement universel 2025
Published on 03/27/2026 at 18:40, 10 hours 46 minutes ago 2026 share capital increase reserved for members of the Saint-Gobain Group employee savings plan
